Tympanogen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $1.47M

  • Investors
  • 28

Tympanogen General Information

Description

Developer of medical devices for ear, nose, and throat (ENT) designed to replace traditional surgical procedures with clinic visits. The company's devices include wound-healing therapies that replace traditional surgical repair of eardrum perforations while decreasing healthcare costs by using technology, enabling surgeons to simplify existing surgical procedures and improve treatment outcomes.

Contact Information

Website
www.tympanogen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 800 East Leigh Street
  • Richmond, VA 23219
  • United States
+1 (919)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Medical Supplies
Vertical(s)
HealthTech
Corporate Office
  • 800 East Leigh Street
  • Richmond, VA 23219
  • United States
+1 (919)

Tympanogen Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tympanogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
23. Later Stage VC (Series A2) 01-Jun-2026 $1.47M Completed Clinical Trials - Phase 1
22. Later Stage VC (Series A1) 17-Feb-2025 Completed Clinical Trials - Phase 1
21. Later Stage VC (Series A) 31-Dec-2023 Completed Pre-Clinical Trials
20. Grant 25-Jul-2023 Completed Pre-Clinical Trials
19. Accelerator/Incubator 21-Oct-2022 Completed Pre-Clinical Trials
18. Seed Round 31-Dec-2022 Completed Pre-Clinical Trials
17. Grant 01-Nov-2021 Completed Pre-Clinical Trials
16. Accelerator/Incubator Completed Pre-Clinical Trials
15. Grant 01-Jul-2020 $80K $420K Completed Pre-Clinical Trials
14. Grant 16-Dec-2019 $250K $420K Completed Pre-Clinical Trials
To view Tympanogen’s complete valuation and funding history, request access »

Tympanogen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-5
Series A-2
Series A-4 236,520 $0.000010 $0.52 $0.52 1x $0.52 2.97%
Series A-3 618,099 $0.000010 $0.83 $0.83 1x $0.83 7.77%
To view Tympanogen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Tympanogen Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Tympanogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023309008-A1 Photocurable hydrogel compositions Pending 20-Jul-2022
EP-4558546-A1 Photocurable hydrogel compositions Pending 20-Jul-2022
EP-4558546-A4 Photocurable hydrogel compositions Pending 20-Jul-2022
US-20260306710-A1 Photocurable hydrogel compositions Pending 20-Jul-2022
WO-2024020475-A1 Photocurable hydrogel compositions Inactive 20-Jul-2022 C08J3/075
To view Tympanogen’s complete patent history, request access »

Tympanogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tympanogen Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
TiE Houston Angels Angel Group Minority
Cowtown Angels Angel Group Minority
Frontier Angels Angel Group Minority
Keiretsu Capital Venture Capital Minority
Keiretsu Forum Angel Group Minority
You’re viewing 5 of 28 investors. Get the full list »

Ready to get started?

Request a free trial

Tympanogen FAQs

  • When was Tympanogen founded?

    Tympanogen was founded in 2014.

  • Where is Tympanogen headquartered?

    Tympanogen is headquartered in Richmond, VA.

  • What is the size of Tympanogen?

    Tympanogen has 10 total employees.

  • What industry is Tympanogen in?

    Tympanogen’s primary industry is Therapeutic Devices.

  • Is Tympanogen a private or public company?

    Tympanogen is a Private company.

  • What is the current valuation of Tympanogen?

    The current valuation of Tympanogen is .

  • What is Tympanogen’s current revenue?

    The current revenue for Tympanogen is .

  • How much funding has Tympanogen raised over time?

    Tympanogen has raised $6M.

  • Who are Tympanogen’s investors?

    TiE Houston Angels, Cowtown Angels, Frontier Angels, Keiretsu Capital, and Keiretsu Forum are 5 of 28 investors who have invested in Tympanogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process